JUNS (Jupiter Neurosciences, Inc. Common Stock) Stock Analysis - SEC Filings

Jupiter Neurosciences, Inc. Common Stock (JUNS) is a publicly traded Healthcare sector company. As of May 20, 2026, JUNS trades at $0.35 with a market cap of $12.06M and a P/E ratio of -1.38. JUNS moved +7.81% today. Year to date, JUNS is -68.32%; over the trailing twelve months it is -43.16%. Its 52-week range spans $0.31 to $19.51. Rallies surfaces JUNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find JUNS SEC filings?

Rallies organizes JUNS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

JUNS Key Metrics

Key financial metrics for JUNS
MetricValue
Price$0.35
Market Cap$12.06M
P/E Ratio-1.38
EPS$-0.25
Dividend Yield0.00%
52-Week High$19.51
52-Week Low$0.31
Volume194.68M
Avg Volume0
Revenue (TTM)$21.80K
Net Income$-8.64M
Gross Margin0.00%

Latest JUNS News

Recent JUNS Insider Trades

  • Silva Alison D. bought 250 (~$256.575) on Jul 1, 2025.
  • Silva Alison D. bought 250 (~$257.175) on Jul 1, 2025.
  • Silva Alison D. bought 250 (~$258.5) on Jul 1, 2025.

JUNS Analyst Consensus

JUNS analyst coverage data. Average price target: $0.00.

Common questions about JUNS

Where can I find JUNS SEC filings?
Rallies organizes JUNS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show JUNS 10-K and 10-Q filings?
Rallies organizes JUNS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is JUNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JUNS. It does not provide personalized investment advice.
JUNS

JUNS